200 related articles for article (PubMed ID: 31990345)
1. Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression.
Qi Y; Tan M; Zheng M; Jin S; Wang H; Liu J; Wang P; Nie X; Gao L; Lin B
Jpn J Clin Oncol; 2020 Mar; 50(3):241-253. PubMed ID: 31990345
[TBL] [Abstract][Full Text] [Related]
2. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
Sun Y; Wang C; Yang H; Ma X
Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
[TBL] [Abstract][Full Text] [Related]
3. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
[TBL] [Abstract][Full Text] [Related]
4. Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway.
Zhang J; Yang Y; Zhang Z; He Y; Liu Z; Yu Y; Wu S; Cai B; Feng Y
Cancer Lett; 2013 Oct; 339(2):279-87. PubMed ID: 23142288
[TBL] [Abstract][Full Text] [Related]
5. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F
Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926
[TBL] [Abstract][Full Text] [Related]
6. Histone acetyltransferase MOF is involved in suppression of endometrial cancer and maintenance of ERα stability.
Wu Y; Zeng K; Wang C; Wang S; Sun H; Liu W; Wang X; Niu J; Cong SY; Zhou X; Zhao Y
Biochem Biophys Res Commun; 2019 Feb; 509(2):541-548. PubMed ID: 30598260
[TBL] [Abstract][Full Text] [Related]
7. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
8. Significance of nuclear p-Akt in endometrial carcinogenesis: rapid translocation of p-Akt into the nucleus by estrogen, possibly resulting in inhibition of apoptosis.
Abe N; Watanabe J; Tsunoda S; Kuramoto H; Okayasu I
Int J Gynecol Cancer; 2011 Feb; 21(2):194-202. PubMed ID: 21270601
[TBL] [Abstract][Full Text] [Related]
9. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
10. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
Zhang G; Cheng Y; Zhang Q; Li X; Zhou J; Wang J; Wei L
Mol Med Rep; 2018 Mar; 17(3):4245-4252. PubMed ID: 29328374
[TBL] [Abstract][Full Text] [Related]
11. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
12. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
Dai H; Zhang P; Zhao S; Zhang J; Wang B
Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
[TBL] [Abstract][Full Text] [Related]
14. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
Zhang J; Zhang B; Yin Z; Chen F; Liu T; Xu H; Liu Y; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):932-7. PubMed ID: 25608995
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway.
He YY; Cai B; Yang YX; Liu XL; Wan XP
Cancer Sci; 2009 Jun; 100(6):1051-61. PubMed ID: 19432902
[TBL] [Abstract][Full Text] [Related]
16. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.
Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X
J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803
[TBL] [Abstract][Full Text] [Related]
17. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
[TBL] [Abstract][Full Text] [Related]
18. BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway.
Wang F; Chen Q; Huang G; Guo X; Li N; Li Y; Li B
BMC Cancer; 2018 Nov; 18(1):1128. PubMed ID: 30445932
[TBL] [Abstract][Full Text] [Related]
19. Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways.
Zhang Z; Zhou D; Lai Y; Liu Y; Tao X; Wang Q; Zhao G; Gu H; Liao H; Zhu Y; Xi X; Feng Y
Cancer Lett; 2012 Jun; 319(1):89-97. PubMed ID: 22222214
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and estrogen receptor induce matrix metalloproteinase-26 expression in endometrial carcinoma cells.
Nishi H; Kuroda M; Isaka K
Oncol Rep; 2013 Aug; 30(2):751-6. PubMed ID: 23754174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
